New England Patriots
1
30M
1
0.02
1
- Areas of investment
Summary
In 1959 was created New England Patriots, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Foxboro. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the New England Patriots, startups are often financed by Atlas Peak Capital. The meaningful sponsors for the fund in investment in the same round are The Kraft Group, SR One, Partners Innovation Fund. In the next rounds fund is usually obtained by SR One, OUP (Osage University Partners), MRL Ventures Fund.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Biotechnology. Among the various public portfolio startups of the fund, we may underline Spero Therapeutics For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The higher amount of exits for fund were in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2015.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Investments by industry
- Therapeutics (1)
- Biotechnology (1)
- Medical Device (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Spero Therapeutics | 08 Jun 2015 | Biotechnology, Medical Device, Therapeutics | Early Stage Venture | 30M | United States, Cambridge, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.